Table of Contents

company-logo

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.

Eliem Therapeutics Dividend Announcement

• Eliem Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Eliem Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Eliem Therapeutics Dividend History

Eliem Therapeutics Dividend Yield

Eliem Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Eliem Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Eliem Therapeutics Financial Ratios

P/E ratio-2.42
PEG ratio0.03
P/B ratio0.70
ROE-47.03%
Payout ratio0.00%
Current ratio60.41
Quick ratio60.41
Cash Ratio59.65

Eliem Therapeutics Dividend FAQ

Does Eliem Therapeutics stock pay dividends?
Eliem Therapeutics does not currently pay dividends to its shareholders.
Has Eliem Therapeutics ever paid a dividend?
No, Eliem Therapeutics has no a history of paying dividends to its shareholders. Eliem Therapeutics is not known for its dividend payments.
Why doesn't Eliem Therapeutics pay dividends?
There are several potential reasons why Eliem Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Eliem Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Eliem Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Eliem Therapeutics a dividend aristocrat?
Eliem Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Eliem Therapeutics a dividend king?
Eliem Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Eliem Therapeutics a dividend stock?
No, Eliem Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Eliem Therapeutics stocks?
To buy Eliem Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Eliem Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.